Medicare Enrolled
Dr. Mark Silverman, DO
Neurology · Farmington Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Silverman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Silverman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Silverman
Dr. Mark Silverman is a neurology specialist in Farmington Hills, MI, with 21 years of NPI registration. Based on federal Medicare data, Dr. Silverman performed 1,897 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Silverman received a total of $295,714 from 85 pharmaceutical and/or device companies across 1965 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Silverman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 9% volume in MI
$295,714 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,897
Medicare services
Top 9% in MI for neurology
Not available
Unique patients (not deduplicated)
$110
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
976 | $95 | $155 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
226 | $229 | $563 |
| New patient office visit, complex (60-74 min) | 139 | $164 | $290 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
112 | $96 | $241 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
88 | $27 | $75 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
87 | $28 | $75 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
61 | $67 | $110 |
| Auditory brainstem response test A test that measures the brain's response to sound to determine hearing thresholds. The results are interpreted and reported by a medical professional. |
39 | $92 | $230 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
36 | $105 | $290 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
34 | $136 | $370 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $134 | $205 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
30 | $140 | $280 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
25 | $66 | $128 |
| Visual evoked potential test A test that measures how quickly electrical signals travel from the eye to the brain in response to visual stimuli. |
11 | $54 | $140 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$295,714
Total received (2018-2024)
Avg $42,245/year across 7 years
Top 5% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
85
Companies
1,965
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$25,680
2023
$20,298
2022
$30,551
2021
$28,454
2020
$36,952
2019
$69,474
2018
$84,304
Payments by company (2024)
Biogen, Inc.
$9,537
Celgene Corporation
$6,738
E.R. Squibb & Sons, L.L.C.
$5,871
EMD Serono, Inc.
$482
Takeda Pharmaceuticals U.S.A., Inc.
$283
Novartis Pharmaceuticals Corporation
$281
Neurocrine Biosciences, Inc.
$281
TG Therapeutics, Inc.
$254
ABBVIE INC.
$220
UCB, Inc.
$155
Lundbeck LLC
$151
CSL Behring
$139
Sumitomo Pharma America, Inc.
$134
Amgen Inc.
$119
Alexion Pharmaceuticals, Inc.
$110
ACADIA Pharmaceuticals Inc
$106
Genentech USA, Inc.
$92
Eisai Inc.
$86
Lilly USA, LLC
$80
CATALYST PHARMACEUTICALS, INC.
$72
ARGENX US, INC.
$59
JAZZ PHARMACEUTICALS INC.
$57
Octapharma USA, Inc.
$57
Teva Pharmaceuticals USA, Inc.
$50
Mallinckrodt Hospital Products Inc.
$39
Merz Pharmaceuticals, LLC
$35
AstraZeneca Pharmaceuticals LP
$30
PFIZER INC.
$28
SK Life Science, Inc.
$28
LivaNova USA, Inc.
$21
Amneal Pharmaceuticals LLC
$21
Aucta Pharmaceuticals, Inc.
$18
HOSPIRA, INC.
$16
Vanda Pharmaceuticals Inc.
$16
Kyowa Kirin, Inc.
$13
Top 3 companies account for 86.2% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$143,942
GENZYME CORPORATION
$65,020
EMD Serono, Inc.
$33,441
Celgene Corporation
$8,902
E.R. Squibb & Sons, L.L.C.
$8,869
Supernus Pharmaceuticals, Inc.
$7,336
Novartis Pharmaceuticals Corporation
$7,152
Teva Pharmaceuticals USA, Inc.
$2,892
Acorda Therapeutics, Inc
$2,486
UCB, Inc.
$1,413
Neurocrine Biosciences, Inc.
$830
CSL Behring
$810
US WorldMeds, LLC
$643
Janssen Pharmaceuticals, Inc
$620
Promius Pharma LLC
$615
Amgen Inc.
$575
Eisai Inc.
$552
AbbVie Inc.
$530
ACADIA Pharmaceuticals Inc
$527
Genentech USA, Inc.
$484
Avanir Pharmaceuticals, Inc.
$432
Lundbeck LLC
$431
Alexion Pharmaceuticals, Inc.
$427
ABBVIE INC.
$408
TG THERAPEUTICS, INC.
$404
Takeda Pharmaceuticals U.S.A., Inc.
$355
Sumitomo Pharma America, Inc.
$325
TG Therapeutics, Inc.
$254
SK Life Science, Inc.
$235
LivaNova USA, Inc.
$234
Lilly USA, LLC
$233
Kyowa Kirin, Inc.
$226
Adamas Pharmaceuticals, Inc.
$223
Grifols USA, LLC
$212
Neurelis, Inc.
$211
Horizon Therapeutics plc
$179
Sunovion Pharmaceuticals Inc.
$170
Boston Scientific Corporation
$165
Validus Pharmaceuticals LLC
$158
PFIZER INC.
$154
Corium, LLC
$149
EISAI INC.
$148
AbbVie, Inc.
$119
Allergan, Inc.
$118
Alnylam Pharmaceuticals Inc.
$117
Allergan Inc.
$111
JAZZ PHARMACEUTICALS INC.
$109
Octapharma USA, Inc.
$105
ARGENX US, INC.
$103
AstraZeneca Pharmaceuticals LP
$95
Medtronic Vascular, Inc.
$92
CATALYST PHARMACEUTICALS, INC.
$90
MDD US Operations, LLC
$87
Biohaven Pharmaceuticals, Inc.
$84
BANNER LIFE SCIENCES, LLC
$83
Biohaven Pharmaceutical Holding Company Ltd.
$81
Akcea Therapeutics, Inc.
$77
Zogenix Inc.
$66
Bausch Health US, LLC
$64
Merz Pharmaceuticals, LLC
$62
Upsher-Smith Laboratories LLC
$56
Medtronic USA, Inc.
$52
MITSUBISHI TANABE PHARMA AMERICA, INC.
$52
Amneal Pharmaceuticals LLC
$46
Cala Health, Inc.
$42
Bayer HealthCare Pharmaceuticals Inc.
$40
Mallinckrodt Hospital Products Inc.
$39
Nevro Corp.
$33
Mitsubishi Tanabe Pharma America, Inc.
$32
Otsuka America Pharmaceutical, Inc.
$26
GRT US Holding, Inc.
$25
Catalyst Pharmaceuticals, Inc.
$23
UPSHER-SMITH LABORATORIES LLC
$21
Averitas Pharma Inc.
$19
Aucta Pharmaceuticals, Inc.
$18
Otsuka Pharmaceutical Development & Commercialization, Inc.
$18
Collegium Pharmaceutical, Inc.
$17
GE HEALTHCARE
$17
HOSPIRA, INC.
$16
Vanda Pharmaceuticals Inc.
$16
Scilex Pharmaceuticals Inc.
$15
Aprecia Pharmaceuticals, LLC
$14
Exeltis, USA Inc.
$13
Banner Life Sciences, LLC
$13
Impax Laboratories, Inc.
$11
Top 3 companies account for 82.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADUHELM · AFINITOR · AGAMREE · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · CALA TRIO · CERDELGA · COMIRNATY · COPAXONE · DISEASE STATE · DUOPA · Duopa · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · EVUSHELD · Enspryng · Equetro · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GENERAL - THERAPIES · GILENYA · GOCOVRI · Gamunex-C · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · Kcentra · LEMTRADA · LUMIZYME · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NEXVIAZYME · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Omnia · Ongentys · PANZYGA · PIPELINE-MS · PLEGRIDY · POMPE - DISEASE · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · QULIPTA · QUTENZA · Qutenza · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Reveal LINQ · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · Spritam · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS - Symmetry · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XARELTO · Xadago · Xeomin · ZEPOSIA · ZINBRYTA · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
356
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
BEAUMONT HOSPITAL - FARMINGTON HILLS
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Silverman is a clinical cardiology specialist, with above-average Medicare volume (top 9% in MI), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Silverman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Silverman performed 976 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Silverman receive payments from pharmaceutical companies?
Yes. Dr. Silverman received a total of $295,714 from 85 companies across 1,965 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Silverman's costs compare to other neurologists in Farmington Hills?
Dr. Silverman's average Medicare payment per service is $110. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Silverman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Farmington Hills
Browse neurologists in Farmington Hills ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MI
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MI
Which MI neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology